<DOC>
	<DOCNO>NCT01147081</DOCNO>
	<brief_summary>Annual trial registration influenza vaccine Begrivac strain composition season 2010/2011 .</brief_summary>
	<brief_title>Safety Immunogenicity , Inactivated Split Influenza Vaccine , Using Strain Composition 2010/2011</brief_title>
	<detailed_description>At enrolment , subject stratify two age stratum ( 18 60 year , 60 year ) . Total duration study three week . Vaccinations administer day 1 . Blood sample collect day 1 ( baseline , vaccination ) day 22 ( three week vaccination ) . Sera test Hemagglutination Inhibition ( HI ) assay . Safety assess 3 week vaccination .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Male female volunteer 18 year age old , mentally competent , willing able give write informed consent prior study entry ; 2 . Individuals able comply study requirement ; 3 . Individuals good health determine medical history , physical examination clinical judgment investigator . Written informed consent must obtain subject enrollment study nature study explain . 1 . Individuals behavioral cognitive impairment psychiatric disease , opinion investigator , may interfere subject 's ability participate study ; 2 . Individuals serious chronic acute disease ( judgment investigator ) , include limited : 1 . Cancer , except localize skin cancer ; 2 . Advanced congestive heart failure ; 3 . Chronic obstructive pulmonary disease ( COPD ) ; 4 . Autoimmune disease ( include rheumatoid arthritis ) ; 5 . Acute progressive hepatic disease ; 6 . Acute progressive renal disease ; 7 . Severe neurological psychiatric disorder ; 8 . Severe asthma ; 3 . Individuals history anaphylactic reaction and/or serious allergic reaction follow vaccination , proven hypersensitivity component study vaccine ( e.g . ovalbumin , chicken protein , chicken feather , influenza viral protein , Polymyxin B ; 4 . Individuals know suspect ( high risk develop ) impairment/alteration immune function ( exclude normally associate advanced age ) resulting , example , : 1. receipt immunosuppressive therapy ( parenteral oral corticosteroid cancer chemotherapy/radiotherapy ) within past 60 day full length study ; 2. receipt immunostimulants ; 3. receipt parenteral immunoglobulin preparation , blood product and/or plasma derivates within past 3 month full length study ; 4. suspect know HIV infection HIVrelated disease ; 5 . Individuals know suspected history drug alcohol abuse ; 6 . Individuals bleed diathesis condition associate prolonged bleeding time investigator 's opinion would interfere safety subject ; 7 . Female pregnant nursing ( breastfeed ) mother females childbearing age plan use acceptable birth control measure , duration study . Adequate contraception define hormonal ( e.g. , oral , injection , transdermal patch , implant , cervical ring ) , barrier ( e.g. , condom spermicide diaphragm spermicide ) , ,intrauterine device ( IUD ) , monogamous relationship vasectomize partner vasectomize 6 month prior subject 's study entry ; 8 . Individuals able comprehend follow require study procedure whole period study ; 9 . Individuals within past 12 month receive one injection influenza vaccine ; 10 . Individuals within past 6 month : 1. laboratory confirm seasonal pandemic influenza disease ; 2. receive seasonal pandemic influenza vaccine ; 11 . Individuals acute chronic infection require systemic antibiotic treatment antiviral therapy within last 7 day 12 . Individuals experience fever ( i.e. , axillary temperature ≥ 38°C ) within last 3 day intend study vaccination 13 . Individuals participate clinical trial another investigational product 4 week prior first study visit intent participate another clinical study time conduct study . 14 . Individuals receive vaccine within 4 week prior enrollment study planning receive vaccine within 4 week study vaccine 15 . Individuals receive blood , blood product and/or plasma derivative parenteral immunoglobulin preparation past 12 week full length study 16 . Individuals part study personnel close family member conduct study . 17 . Individuals history illness , opinion investigator , might interfere result study pose additional risk subject due participation study . 18 . BMI &gt; 35 kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Influenza vaccine</keyword>
	<keyword>Vaccine</keyword>
</DOC>